| European Case Law Identifier: | ECLI:EP:BA:1995:T014394.19951006 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 06 October 1995 | ||||||||
| Case number: | T 0143/94 | ||||||||
| Application number: | 87106650.2 | ||||||||
| IPC class: | A61K 7/06 | ||||||||
| Language of proceedings: | DE | ||||||||
| Distribution: | |||||||||
| Download and more information: |
|
||||||||
| Title of application: | - | ||||||||
| Applicant name: | Mai, Jutta | ||||||||
| Opponent name: | Erwin Stückler | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | A claim directed to the use of a substance or composition for the production of a medicament for a therapeutic application does not conflict with Articles 52(4) or 57 EPC (see G 1/83, G 5/83, G 6/83), irrespective of the purpose (protection of a first medical use of a substance or composition, or protection of a further medical use) served by that claim (point 3.2). Accordingly, prior evidence of a further medical use is not required for this form of claim to be included in a patent application (point 3.2). | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Novelty - new form of administering substance with known use (yes) Inventive step (yes) - non-obvious alternative form of administration |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t940143ep1.html
Date retrieved: 17 May 2021
9 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPO Guidelines - G Patentability
Offical Journal of the EPO
XOJ EPO SE 1/2021, p179 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2020)
XOJ EPO SE 1/2020, p174 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2019)
XOJ EPO SE 1/2019, p158 - XVI. - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2018)